AU2719597A - New pharmaceutical formulation of a thrombin inhibitor for parenteral use - Google Patents

New pharmaceutical formulation of a thrombin inhibitor for parenteral use

Info

Publication number
AU2719597A
AU2719597A AU27195/97A AU2719597A AU2719597A AU 2719597 A AU2719597 A AU 2719597A AU 27195/97 A AU27195/97 A AU 27195/97A AU 2719597 A AU2719597 A AU 2719597A AU 2719597 A AU2719597 A AU 2719597A
Authority
AU
Australia
Prior art keywords
pharmaceutical formulation
thrombin inhibitor
parenteral use
new pharmaceutical
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU27195/97A
Inventor
Anna Lundgren
Ulla Stjernfelt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
Astra AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra AB filed Critical Astra AB
Publication of AU2719597A publication Critical patent/AU2719597A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/005—Enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU27195/97A 1996-04-24 1997-04-22 New pharmaceutical formulation of a thrombin inhibitor for parenteral use Abandoned AU2719597A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9601556 1996-04-24
SE9601556A SE9601556D0 (en) 1996-04-24 1996-04-24 New pharmaceutical formulation of a thrombin inhibitor for parenteral use
PCT/SE1997/000676 WO1997039770A1 (en) 1996-04-24 1997-04-22 New pharmaceutical formulation of a thrombin inhibitor for parenteral use

Publications (1)

Publication Number Publication Date
AU2719597A true AU2719597A (en) 1997-11-12

Family

ID=20402321

Family Applications (1)

Application Number Title Priority Date Filing Date
AU27195/97A Abandoned AU2719597A (en) 1996-04-24 1997-04-22 New pharmaceutical formulation of a thrombin inhibitor for parenteral use

Country Status (6)

Country Link
AR (1) AR006664A1 (en)
AU (1) AU2719597A (en)
ID (1) ID17334A (en)
SE (1) SE9601556D0 (en)
WO (1) WO1997039770A1 (en)
ZA (1) ZA973062B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9802938D0 (en) 1998-09-01 1998-09-01 Astra Ab Improved stability for injection solutions
SE9802973D0 (en) * 1998-09-03 1998-09-03 Astra Ab Immediate release tablet
SE9900070D0 (en) 1999-01-13 1999-01-13 Astra Ab New use
FR2793418B1 (en) * 1999-05-11 2001-07-27 Synthelabo GALENIC FORMULATIONS OF ANTITHROMBOTIC AGENTS FOR SUBCUTANEOUS ADMINISTRATION
SE9902202D0 (en) 1999-06-10 1999-06-10 Astra Ab Production of aggregates
SE0001803D0 (en) 2000-05-16 2000-05-16 Astrazeneca Ab New compounds i
GB0014136D0 (en) * 2000-06-10 2000-08-02 Astrazeneca Ab Combination therapy
GB0014134D0 (en) * 2000-06-10 2000-08-02 Astrazeneca Ab Combination therapy
PE20020300A1 (en) 2000-08-22 2002-05-10 Pharmacia Corp COMPOSITION OF SOLUTION OF AN ANTIBIOTIC DRUG BASED ON OXAZOLIDINONE WITH IMPROVEMENT OF DRUG LOAD
US6462021B1 (en) 2000-11-06 2002-10-08 Astrazeneca Ab Use of low molecular weight thrombin inhibitor
AR035216A1 (en) 2000-12-01 2004-05-05 Astrazeneca Ab MANDELIC ACID DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE DERIVATIVES, USE OF THESE DERIVATIVES FOR THE MANUFACTURE OF MEDICINES, TREATMENT METHODS, PROCESSES FOR THE PREPARATION OF THESE DERIVATIVES, AND INTERMEDIARY COMPOUNDS
SE0101762D0 (en) * 2001-05-18 2001-05-18 Astrazeneca Ab New use
SE0201659D0 (en) * 2002-05-31 2002-05-31 Astrazeneca Ab Modified release pharmaceutical formulation
SE0201661D0 (en) 2002-05-31 2002-05-31 Astrazeneca Ab New salts
SE0201658D0 (en) * 2002-05-31 2002-05-31 Astrazeneca Ab Immediate release pharmaceutical formulation
DK1569912T3 (en) 2002-12-03 2015-06-29 Pharmacyclics Inc 2- (2-hydroxybiphenyl-3-yl) -1h-benzoimidazole-5-carboxamidine derivatives as factor VIIa inhibitors.
TW200827336A (en) 2006-12-06 2008-07-01 Astrazeneca Ab New crystalline forms
EP2836206A4 (en) * 2012-04-10 2015-11-04 Rubicon Res Private Ltd Controlled release pharmaceutical formulations of direct thrombin inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3346123A1 (en) * 1983-12-21 1985-06-27 Janssen Pharmaceutica, N.V., Beerse PHARMACEUTICAL PREPARATIONS OF SUBSTANCES MEDICAL OR UNSTABLE IN WATER AND METHOD FOR THE PRODUCTION THEREOF
DK93993D0 (en) * 1993-08-17 1993-08-17 Finn Molke Borgbjerg USE OF 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN FOR THE PREPARATION OF A SYSTEMIC ANALGETIC OPIOID PREPARATION

Also Published As

Publication number Publication date
WO1997039770A1 (en) 1997-10-30
AR006664A1 (en) 1999-09-08
ZA973062B (en) 1997-10-24
SE9601556D0 (en) 1996-04-24
ID17334A (en) 1997-12-18

Similar Documents

Publication Publication Date Title
AU2719597A (en) New pharmaceutical formulation of a thrombin inhibitor for parenteral use
AU3832895A (en) Thrombin inhibitors
AU4875196A (en) Novel thrombin inhibitors
AU4787596A (en) Thrombin inhibitors
AU7497596A (en) Thrombin inhibitors
AU7145294A (en) Heterocyclic thrombin inhibitors
AU5208193A (en) Guanidinyl-substituted heterocyclic thrombin inhibitors
AU6961894A (en) Diamondoid derivatives for pharmaceutical use
AU4172397A (en) Lactam inhibitors of thrombin
AU4791797A (en) 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors
AU3102397A (en) Metalloprotease inhibitors
AU3941797A (en) Novel thrombin inhibitors
AU8245898A (en) Apparatus for sanitary packing of used objects
AU7139598A (en) Protease inhibitors
AU3459897A (en) Differentiation inhibitor
AU1808999A (en) Fibrinolytic inhibitor for sealant
AU692123B2 (en) 5alpha-reductase inhibitors
AU6183494A (en) Guanidinyl- or amidinyl-substituted heterocyclic thrombin inhibitors
AU4641097A (en) New pharmaceutical parenteral formulation of a thrombin inhibitor
AU3551297A (en) Polymerisation inhibitor
AU2277597A (en) New inhibitors of sh2-mediated processes
AU4330097A (en) Pharmaceutical compounds
AU3396697A (en) Thrombin inhibitor
AU4128597A (en) Phosphatidylcholine synthesis inhibitors
AUPM982594A0 (en) HIV protease inhibitors